Navigation Links
Gastric Bypass And Laparoscopic Reflux Surgery Gaining Popularity

crease the upflow of stomach acid to the esophagus.

Researchers selected 98 chronic GERD patients who required long-term therapy. Researchers randomly divided the patient sample into two groups; one group initiated treatment with PPI and the other underwent LNF. Researchers evaluated patient symptoms every three months and conducted a 24 hour pH test on all patients at one year.

Study results showed that 24 hour pH levels and GERD symptoms improved in both the PPI and surgery groups. However, at one year follow-up, the overall symptom control score for patients on medication remained stable, while surgical patients experienced a significant improvement in their symptoms increasing from 73.3 to 90.2 on 100 point global rating scale. The global rating scale is an assessment of patient satisfaction with symptom control, on a scale of 0 (poor) to 100 (excellent).

‘Although there is no known cure for GERD, this study reveals that patients maintaining long-term PPI therapy may experience a greater improvement in their symptoms with surgical intervention’ said Mehran Anvari, M.D., of McMaster University in Ontario and lead study author. ‘This minimally invasive surgical procedure may allow some patients to manage GERD symptoms and forgo a long-term drug regimen.’

Source: Eurealert
'"/>




Page: 1 2 3

Related medicine news :

1. The Reason For Loss Of Appetite After Gastric Bypass
2. Gastric bypass surgery reduces risk of heart disease
3. Surgeons Perform Robotic Gastric Bypass Surgery
4. Helicobacter pylori Antibiotic Treatment of Peptic Ulcer May not Prevent Gastric lymphomas
5. New Gastric Cancer Drug Unlikely to Benefit Kidney Cancer Patients
6. Migraine Patients Suffer From Gastric Stasis
7. Gastric bypass can cause deficiency of Vitamin A
8. For Super-Obese Patients, Duodenal Switch Beats Gastric Bypass
9. Long-time Gastric Acid Suppression Does Not Increase The Risk Of Cancer
10. Gastric Bypass Surgery May Lead to Increased Kidney Stone Risk
11. Robotically Assisted Colo-resection And Gastric Bypass Surgeries Are Becoming Popular
Post Your Comments:
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
(Date:12/5/2009)... steps to eliminate triggers, experts advise , , SATURDAY, Dec. ... with allergies and asthma can have bad reactions to ... to prevent sneezing and wheezing, according to the American ... who are allergic to live evergreens may choose to ...
(Date:12/5/2009)... of International Solutions, an innovative new international private medical insurance plan ... addition to offering customers the flexibility to add or remove a ... Solutions enables customers to tailor their benefits to complement those already ... ...
(Date:12/4/2009)... (NYSE: VAR ) announced today that its Board ... Stockholders for February 11, 2010 with a record date of ... Crowne Plaza Cabana Hotel, 4290 El Camino Real, Palo Alto, ... webcast by Thomson Financial and can be accessed at Varian ...
(Date:12/4/2009)... Medithrive, Inc. has won the Patient,s Choice Award as ... popular vote conducted by the online website, www.weedmaps.com. ... Bay community has selected Medithrive as the preeminent location ... rise and popularity of Medithrive confirms the obvious: a ...
Breaking Medicine News(10 mins):Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2
... the Scandinavian Prostate Cancer Group Study 4 (SPCG-4) reported ... watchful waiting after a median of 8.2 years of ... Sweden the results after 3 more years of follow-up ... , The SPCG-4 trial which predominantly included ...
... more than one year after it was created, the ... of Texas M. D. Anderson Cancer Center has ... aimed at inspiring generations of women scientists to come.Legends ... at M. D. Anderson Cancer Center presents the reflections ...
... 2009 Forest Laboratories, Inc. (NYSE: FRX ... Administration (FDA) has approved the Company,s supplemental New Drug ... and maintenance treatment of Major Depressive Disorder (MDD) in ... only the second antidepressant to be approved for the ...
... treatments for cognitive disorders, researchers say , , FRIDAY, ... functions on "the edge of chaos," at a ... U.K.-based researchers who said their finding could help ... , The researchers used medical imaging to ...
... MEDICAL CORP. (NYSE: CMN ) announced the ... President and Chief Executive Officer. Mr. Krakauer will also ... Cantel in September 2004, Mr. Krakauer served as Executive Vice ... Board concurrently appointed Seth R. Segel, Senior Vice President - ...
... Today, the Migraine Research Foundation (MRF) announced a new ... adolescent migraine called FOR OUR CHILDREN. The new ... the understanding of migraine and its causes and treatments ... , Migraine is very common in children ...
Other Medicine News:Health News:SPCG-4 trial: Update on watchful waiting versus radical prostatectomy 2Health News:New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer 2Health News:New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer 3Health News:New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer 4Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 2Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 3Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 4Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 5Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 6Health News:Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments 2Health News:New initiative to support pediatric migraine research is announced 2
(Date:12/4/2009)... highlighted a new report published by the ... that identifies 97 new drugs and vaccines in development for ... that the 97 products in development include 23 vaccines and ... or awaiting approval by the U.S. Food and Drug Administration ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
(Date:12/4/2009)... 4 OrthoAccel Technologies, Inc., developers of the ... device to enhance orthodontics, announced the availability of ... PennWell Corporation , a leader in professional education ... The course focuses on patient views about orthodontic ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4New Reagents from New England Biolabs Bring Purity and Increased Value to Sample Prep for Next Generation Sequencing 57976 1Healthcare Reform 3A Driving Healthcare Costs Down Through Improved Efficiency and Quality of Care 57974 1Healthcare Reform 3A Driving Healthcare Costs Down Through Improved Efficiency and Quality of Care 57974 2Healthcare Reform 3A Driving Healthcare Costs Down Through Improved Efficiency and Quality of Care 57974 3Cardinal Health Introduces Expanded Suite of Services to Help Hospital Pharmacies Improve Cost Containment Workflow Patient Safety 57971 1Cardinal Health Introduces Expanded Suite of Services to Help Hospital Pharmacies Improve Cost Containment Workflow Patient Safety 57971 2Cardinal Health Introduces Expanded Suite of Services to Help Hospital Pharmacies Improve Cost Containment Workflow Patient Safety 57971 3Cardinal Health Introduces Expanded Suite of Services to Help Hospital Pharmacies Improve Cost Containment Workflow Patient Safety 57971 4
... Schering-Plough,Corporation (NYSE: SGP ), a leader ... C virus (HCV) infection, announced today that final,results ... several other clinical studies,with PEGINTRON(TM) (peginterferon alfa-2b) and ... the European Association for the,Study of the Liver ...
... Clinical Trials, SANTA MONICA, Calif., April 16 ... importance of its funding in,enabling clinical trials for ... Watchdog said today, seriously undercutting the agency,s,credibility and ... Last week the California Institute For Regenerative ...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 9California Stem Cell Agency Exaggerated Its Role in Funding Key Research 2
The Atakr II RF Generator provides high power output with the integral safety of closed-loop temperature control using the embedded thermocouples in Medtronic RF ablation catheters....
... only truly dedicated electrophysiology system on the ... System incorporates Fischer's patented "C inside a ... support personnel the ultimate in patient access ... ceiling suspended EPX2 minimizes equipment footprint and ...
... Bi-Plane Electrophysiology imaging have become more acute. ... and reduce radiation exposure to both patient ... between Single and Bi-Plane systems. In ... leadership position in price/value relationship, four bi-plane ...
... office efficiency by reducing errors and eliminating ... software solution, you can spend less time ... and more time on your patient care. ... practice solution. With over 50,000 installations and ...
Medicine Products: